Abstract
Research samples are invaluable scientific assets that support the foundation of new drug discovery. Research suggests that standardized management of these materials can contribute to budget savings, cost avoidance, and process efficiencies that can reduce development time. Unfortunately, many research organizations still employ a siloed approach where research samples are scattered between multiple laboratories and testing facilities based on specific research initiatives. This management model presents numerous bottlenecks, such as delay in finding materials, extended distribution times in shipping materials, and additional cost due to the lack of economies of scale. By taking a holistic approach to comprehensive sample management in which every stage of the sample lifecycle is considered, an organization can maximize their sample inventories.
Get full access to this article
View all access options for this article.